2002 Annual Report

For the Fiscal Year Ended Sept. 30 (Dollars in thousands)	2002	2001

Assets
Current Assets	73,721	83,610
Investments	331,378	353,827
Assets Whose Use Is Limited	1,055	1,351
Property, Plant, and Equipment, net	218,304	213,288
Contributions Receivable, less current portion	20,031	15,427
Other Assets	7,853	5,958
Total Assets	$652,342	$673,461

Liabilities and Net Assets
Current Liabilities	93,069	99,676
Long-Term Debt and Other Liabilities	144,919	145,880
Net Assets
Unrestricted	198,526	221,532
Temporarily Restricted	126,148	122,453
Permanently Restricted	89,680	83,920
Subtotal Net Assets	414,354	427,905
Total Liabilities and Net Assets	$652,342	$673,461

Summary Statistical Information
(Unless otherwise noted, includes adult and pediatric patients)	2002	2001
Number of Licensed Beds (as of year end)	27	27
Adult Inpatient Discharges	991	969
Infusion Visits	53,790	48,030
Outpatient MD Visits	84,427	79,918
Clinical Trials (via Dana-Farber/Harvard Cancer Center)	519	515